Article
To protect against the threat of counterfeit drugs, the Food and Drug Administration wants drug makers, distributors, and pharmacists to adopt new technologies, including embedded computer chips that wound transmit identifying information, by 2007.
Daily Derm Times: March 25, 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Quoin Files US Patent Applications for Rare Disease Treatments
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Understanding Neomycin-Induced Contact Allergy
Nanoneedles Enhance CRISPR Base Editing for RDEB Treatment, Achieving 96.5% Correction Efficiency